PDF
Antigenicity and infectivity of severe acute respiratory syndrome coronavirus 2 Omicron subvariants EG.5.1, XBB.2.3, FL.1.5.1, and BA.2.86
Haijun Tang1,2,3, Yanhang Zhuo1,2, Xiaohong Du3(
), Frank Xiao-Feng Qin3(), Yi Huang1,2()
PDF
Antigenicity and infectivity of severe acute respiratory syndrome coronavirus 2 Omicron subvariants EG.5.1, XBB.2.3, FL.1.5.1, and BA.2.86
), Frank Xiao-Feng Qin3(), Yi Huang1,2()| 1 | Y Cao, A Yisimayi, F Jian, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608(7923):593-602. |
| 2 | B Meng, A Abdullahi, I Ferreira, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603(7902):706-714. |
| 3 | S Yang, Y Yu, Y Xu, et al. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. Lancet Infect Dis. 2024;24(2):e70-e72. |
| 4 | H Shuai, JF Chan, B Hu, et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature. 2022;603(7902):693-699. |
| 5 | AZ Mykytyn, TI Breugem, MH Geurts, et al. SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models. J Virol. 2023;97(8):e0085123. |
/
| 〈 |
|
〉 |
AI Summary
